As of 2025-07-15, the EV/EBITDA ratio of CervoMed Inc (CRVO) is -2.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRVO's latest enterprise value is 48.90 mil USD. CRVO's TTM EBITDA according to its financial statements is -20.93 mil USD. Dividing these 2 quantities gives us the above CRVO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.4x - 3.5x | 3.0x |
| Forward P/E multiples | 2.4x - 3.5x | 3.0x |
| Fair Price | (7.18) - (10.78) | (8.98) |
| Upside | -201.0% - -251.6% | -226.3% |
| Date | EV/EBITDA |
| 2025-05-30 | -2.37 |
| 2025-05-29 | -2.56 |
| 2025-05-28 | -2.59 |
| 2025-05-27 | -2.61 |
| 2025-05-23 | -2.78 |
| 2025-05-22 | -2.77 |
| 2025-05-21 | -2.80 |
| 2025-05-20 | -2.88 |
| 2025-05-19 | -2.89 |
| 2025-05-16 | -2.88 |
| 2025-05-15 | -2.84 |
| 2025-05-14 | -2.73 |
| 2025-05-13 | -2.86 |
| 2025-05-12 | -2.99 |
| 2025-05-09 | -2.79 |
| 2025-05-08 | -2.92 |
| 2025-05-07 | -2.93 |
| 2025-05-06 | -3.08 |
| 2025-05-05 | -3.27 |
| 2025-05-02 | -3.37 |
| 2025-05-01 | -3.47 |
| 2025-04-30 | -2.98 |
| 2025-04-29 | -3.08 |
| 2025-04-28 | -3.01 |
| 2025-04-25 | -2.84 |
| 2025-04-24 | -2.89 |
| 2025-04-23 | -2.96 |
| 2025-04-22 | -2.89 |
| 2025-04-21 | -3.05 |
| 2025-04-17 | -3.22 |
| 2025-04-16 | -3.12 |
| 2025-04-15 | -3.21 |
| 2025-04-14 | -3.18 |
| 2025-04-11 | -2.79 |
| 2025-04-10 | -2.78 |
| 2025-04-09 | -2.90 |
| 2025-04-08 | -2.73 |
| 2025-04-07 | -3.21 |
| 2025-04-04 | -3.64 |
| 2025-04-03 | -3.69 |
| 2025-04-02 | -4.46 |
| 2025-04-01 | -3.28 |
| 2025-03-31 | -3.01 |
| 2025-03-28 | -3.11 |
| 2025-03-27 | -2.79 |
| 2025-03-26 | -2.53 |
| 2025-03-25 | -2.91 |
| 2025-03-24 | -3.52 |
| 2025-03-21 | -4.69 |
| 2025-03-20 | -3.80 |